CP
Elite in Angina

Dr. Carl J. Pepine

UF Health Cardiology Springhill
Gainesville, FL
Elite
 in Angina
Specialties:Cardiology
Experience:57 Years
Clinical Trials:Currently Recruiting for 6 Trials
Accepts:New PatientsMedicare
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Carl J. Pepine's experience treating your condition:
About Dr. Carl J. Pepine

Carl Pepine is a Cardiologist in Gainesville, Florida. Pepine has been practicing medicine for over 57 years and is rated as an Elite expert by MediFind in the treatment of Angina. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Angina, Coronary Heart Disease, Hypertension, Bone Marrow Aspiration, and Percutaneous Coronary Intervention (PCI). He is licensed to treat patients in Florida. Pepine is currently accepting new patients.

His clinical research consists of co-authoring 424 peer reviewed articles and participating in 20 clinical trials in the past 15 years. In particular, he has co-authored 63 articles and participated in 3 clinical trials in the study of Angina.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Carl J. Pepine it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
Call to see if your plan is accepted.
Locations
4037 Nw 86th Terrace, Gainesville, FL 32606
Background & Education
Graduate Institution
Other, 1966
Specialties
Cardiology
Licenses
Internal Medicine in FL
Hospital Affiliations
UF Health Shands Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Clinical Trials
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Post Myocardial Infarction Heart Failure (CardiAMP Heart Failure Trial)
Enrollment Status: Recruiting
Publish Date: August 03, 2022
Intervention Type: Other, Biological
Study Drug: Autologous Cell Therapy
Study Phase: Phase 3
Characterize the Gut Microbiota in Subjects With Heart Failure and Pre-heart Failure With Preserved Ejection Fraction
Enrollment Status: Recruiting
Publish Date: July 07, 2022
Intervention Type: Other
The Role of Gut Microbiota in Hypertension: Brain-Gut Microbiome-Immune Axis in Hypertension
Enrollment Status: Recruiting
Publish Date: May 24, 2022
Intervention Type: Other
Angiotensin and Neuroimmune Activation in Hypertension
Enrollment Status: Recruiting
Publish Date: May 24, 2022
Intervention Type: Drug
Study Drug: Minocycline
Study Phase: Phase 4
Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Enrollment Status: Recruiting
Publish Date: April 20, 2022
Intervention Type: Drug
Study Drug: Umbilical Cord Lining Stem Cells
Study Phase: Early Phase 1
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Enrollment Status: Recruiting
Publish Date: September 16, 2021
Intervention Type: Drug, Behavioral
Study Drugs: StatinLisinoprilLosartanAspirin
Study Phase: Phase 4
Gut Inflammation and Gut-Gut Microbiome Interactions in the Pathogenesis of Hypertension
Enrollment Status: Active, not recruiting
Publish Date: October 27, 2022
Intervention Type: Other
Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients
Enrollment Status: Not yet recruiting
Publish Date: September 19, 2022
Intervention Type: Drug
Study Drug: Minocycline
Study Phase: Phase 2
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction
Enrollment Status: Active, not recruiting
Publish Date: July 21, 2022
Intervention Type: Procedure
Angiotensin and Neuroimmune Activation in Hypertension
Enrollment Status: Not yet recruiting
Publish Date: May 24, 2022
Intervention Type: Drug, Other
Study Drug: Minocycline
Study Phase: Phase 1/Phase 2
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Enrollment Status: Completed
Publish Date: January 10, 2022
Intervention Type: Biological, Other
Study Phase: Phase 3
A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy
Enrollment Status: Completed
Publish Date: November 05, 2020
Intervention Type: Biological
Study Phase: Phase 1
WISE Ancillary Study Data Analyses: Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis
Enrollment Status: Completed
Publish Date: April 24, 2019
Intervention Type: Drug
Study Phase: Not Applicable
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2019
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Effects of ACE2/Ang-(1-7) on Cardiac Progenitor Cells From Heart Failure Patients and Explant Control
Enrollment Status: Completed
Publish Date: November 27, 2018
Intervention Type: Procedure
A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease
Enrollment Status: Completed
Publish Date: October 14, 2013
Intervention Type: Drug
Study Phase: Phase 4
A Double-Blind, Multicenter, Placebo Controlled Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease.
Enrollment Status: Completed
Publish Date: April 13, 2012
Intervention Type: Drug
Study Phase: Phase 4
INternational VErapamil SR Trandolapril STudy
Enrollment Status: Completed
Publish Date: September 20, 2011
Intervention Type: Drug
Study Phase: Phase 4
View 13 Less Clinical Trials -
424 Total Publications
Heart and brain interactions: is small vessel disease a link?
Journal: European heart journal
Published: November 11, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
JP
Dr. John W. Petersen
Cardiology
Distinguished
Highly rated in
23
conditions
Cardiology

University of Florida Health

UF Health Sports And Exercise Cardiology Springhill

4037 Nw 86th Terrace, 
Gainesville, FL 

John Petersen is a Cardiologist in Gainesville, Florida. Petersen has been practicing medicine for over 19 years and is rated as a Distinguished expert by MediFind in the treatment of Angina. He is also highly rated in 23 other conditions, according to our data. His top areas of expertise are Angina, Coronary Heart Disease, Atrial Fibrillation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in Florida and North Carolina. Petersen is currently accepting new patients.

GC
Dr. Georg J. Couturier
Cardiology
Distinguished
Highly rated in
36
conditions
Cardiology

Central Florida Health

Village Heart & Vein Center (FKA Heart Of The Villages Plc)

8575 Ne 138th Ln, 
Lady Lake, FL 
 58.0 mi

Georg Couturier is a Cardiologist in Lady Lake, Florida. Couturier has been practicing medicine for over 32 years and is rated as a Distinguished expert by MediFind in the treatment of Angina. He is also highly rated in 36 other conditions, according to our data. His top areas of expertise are Angina, Sick Sinus Syndrome, Coronary Heart Disease, Atherosclerosis, and Pacemaker Implantation. He is licensed to treat patients in Florida. Couturier is currently accepting new patients.

DV
Dr. Daniel Vanroy
Interventional Cardiology | Cardiology
Distinguished
Highly rated in
11
conditions
Interventional Cardiology
Cardiology

HCA Florida Healthcare

The Cardiac & Vascular Institute - Gainesville/Terrace

1151 Nw 64th Ter, 
Gainesville, FL 
 2.2 mi

Daniel Vanroy is an Interventional Cardiologist and a Cardiologist in Gainesville, Florida. Vanroy has been practicing medicine for over 31 years and is rated as a Distinguished expert by MediFind in the treatment of Angina. He is also highly rated in 11 other conditions, according to our data. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation. He is licensed to treat patients in Florida. Vanroy is currently accepting new patients.